EF
AVNS

Entrust Financial’s Avanos Medical AVNS Stock Holding History

Entrust Financial’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$622 Hold
25
– – ﹤0.01% 435
2026
Q1 		$351 Hold
25
– – ﹤0.01% 425
2025
Q4 		$281 Buy
+25
New +$286 ﹤0.01% 413

Other funds holding AVNS

SRC
Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Entrust Financial's AVNS Position: Q2 2026 in Review

Entrust Financial held its Avanos Medical (AVNS) position steady in Q2 2026 at 25 shares worth $622. The position accounts for ﹤0.01% of the portfolio, ranked #435.

Entrust Financial first reported a position in AVNS in Q4 2025 and has held it in 3 quarters since. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Entrust Financial held 25 shares of Avanos Medical worth $622 as of Q2 2026.
  • Entrust Financial left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Entrust Financial's portfolio in Q2 2026, its #435 holding.
  • Entrust Financial first reported a position in Avanos Medical in Q4 2025 and has held it in 3 quarters since.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Entrust Financial's 13F filing for Q2 2026, filed 20 Jul 2026.